Default profile
+ 0User Rating

Radhika Poojari, Ph.D.

Primary Affiliation
Indian Institute of Technology Bombay
Status
Professional
City
Mumbai
Country
India

Stats

0
Papers
0
Paper Endorsements
0
Reviews
0
Review Endorsements

Subject:                                       Application for associate editor

 

NAME:                                         Dr. Radhika  J. Poojari

POSITION:                                  Post-Doctoral Fellow

 

ADDRESS:                                  Department of Biosciences and Bioengineering,

                                                      Indian Institute of Technology Bombay (IIT Bombay), 

                                                      Mumbai, India.

EDUCATIONAL QUALIFICATIONS: 

 

DEGREE

 YEAR

UNIVERSITY/ INSTITUTE

FIELD OF STUDY

B.Sc.

May  2000

University of Mumbai, Mumbai, India

Zoology

M.Sc.

April  2002

University of Mumbai, Mumbai, India

Zoology

Ph.D.

April  2010

University of Mumbai, Mumbai, India

Science

 

TITLE OF Ph.D. THESIS:Study of Hepatoprotective and Antitumor Activities of Herbal Drug Preparations in Animals.

PROFESSIONAL EXPERIENCE: 

 

Post Doctoral Fellow (January 2012 – present) at Indian Institute of Technology Bombay (IIT Bombay), Mumbai, India. Working in Indian Institute of Technology Bombay Healthcare Initiative funded project (June 2014 - present).

 

Research Associate (November 2010 – November 2011) at Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Navi Mumbai, India. 

 

Research Interests: 

  1. Nanomedicine as Controlled Drug Delivery Systems, Cancer Nanotechnology

  2. Molecular Medicine and Cancer

  3. Drug Development: Pre-Clinical Pharmacology

  4. Natural Products, Cancer Chemoprevention, Anti-infectives

 

 RESEARCH PUBLICATIONS:    

Poojari, R. (2014). Embelin, a small molecule quinone with a co-clinical power for castrate-resistant prostate cancer. Frontiers in Pharmacology 5, 1 – 2.

 

Poojari, R. (2014).Embelin − a drug of antiquity: shifting the paradigm towards modern medicine. Expert Opinion on Investigational Drugs 23, 427 444.    

 

Poojari, R.and Srivastava, R. (2013). Composite alginate microspheres as the next-generation egg-box carriers for biomacromolecules delivery. Expert Opinion on Drug Delivery 10, 1061–1076.

     Poojari, R. (2013). PLGA: The smart therapeutics goods carrier. Frontiers in Pharmacology   4, 1. 

* Poojari, R., Patil, A. and Gota, V. (2012). Development of botanical medicines for clinical use in Cancer – where are we lacking?, Journal of Postgraduate Medicine 58, 64 68. (*Corresponding author)

 

Poojari, R. (2011). Phytochemical fingerprinting, cytotoxic, antimicrobial, antitubercular,  antimycotic potentials of Sida rhombifolia ssp. retusa and Embelia tsjeriam-cottam, Asia Pacific Journal of Life Sciences 4, 201214.

 

* Poojari, R., Gupta, S., Maru, G., Khade, B. and Bhagwat, S. (2010). Chemopreventive and hepatoprotective effects of Embelin on N – Nitrosodiethylamine and Carbon tetrachloride induced Preneoplasia and Toxicity in rat liver, Asian Pacific Journal of Cancer Prevention 11, 1015 1020. (*Corresponding author)      

 

 * Poojari, R., Gupta, S.,Maru, G.,Khade, B. and Bhagwat, S. (2009). Sida rhombifolia ssp. retusa seed extract inhibits DEN induced murine hepatic Preneoplasia and CCl4 Hepatotoxicity, Asian Pacific Journal of Cancer Prevention 10, 1107 1112. (*Corresponding author) 

BOOK CHAPTERS: 

Poojari, R. (2012). In, Phytochemical fingerprinting, cytotoxic, antimicrobial, antitubercular, antimycotic potentials of Sida rhombifolia ssp. retusa and Embelia tsjeriam-cottam, Asia Pacific Life Sciences Compendium, Vol. 4, Edited by Bandit Chumworathayi, Nova Science Publishers, Inc., New York, pp. 117.

MEMBERSHIP:

Member of UICC (Union Internationale Contra Cancrum) for asian cancer control.

Member of OMICS group.

 

AWARDS / HONOURS:

Post-doctoral Fellowship Award (2012 – present) in Biotechnology and Life Sciences from Department of Biotechnology (DBT), Goverment of India, India.  

      • Normal 4bfdcaf271794a09b2c34f17e682f313
        Journal
        The International Journal of Oncology is a peer-reviewed, open access journal that publishes original research articles, review articles, and essays focused on cancer research, diagnosis, and treatment. The scope of the IJO includes advances in biopsy, endoscopy, and detection methods including CT, MRI, X-Ray, PET, Ultrasound, and SPECT; as well as surgical treatment, chemotherapy and radiotherapies, vaccines and immunotherapies, and nutrition.
      • Normal bf96c1d4c0f243b3b989e28aedb73a3b
        Journal
        The International Journal of Complementary & Alternative Medicine is a peer-reviewed, open access journal that publishes original research papers, review articles, and essays pertaining to complimentary and alternative medicine. The aim of the IJCAM is to promote and highlight progressive research discoveries, as well as comprehensive theoretical works, that can directly improve alternative medicine knowledge and practice. The scope is necessarily broad, and includes alternative cancer therapies, subtle energies and energetic healing, folk medicine and home remedies, holistic medicine, homeopathy, hypnotherapy, immunotherapy, magnetic and electromagnetic field therapy, massage therapy, medicinal plants and herbs, mental and faith healing, mind-body science, music therapy, naturopathic medicine, nutritional and nutraceutical therapies, prayer, shamanic medicine, and related areas that bear upon alternatives to allopathic medicine.
      • Normal e80804c0de954d54812eca378dc5ca96
        Journal
        The International Journal of Developments in Nanotechnology is a peer-reviewed, open access journal that publishes original research papers, review articles, and essays within nanotechnology. The aim of the IJDN is to promote innovative basic science and material applications of nanoscopic engineering, from DNA to silicon, atomic to molecular manipulations. Speculative and theoretical articles are also open to consideration.